Helios 50 MW BESS achieves commercial operations in Hokkaido, Japan TOKYO, Dec. 1, 2025 /PRNewswire/ — Manoa Energy ("Manoa" or the "Company")… CISION PRNewswireDecember 1, 2025
YEAHKA's Q3 In-Store E-Commerce Business Sustains Profitability, Partnering with Renowned Brands Such as Midea, Toshiba, and China Telecom HONG KONG, Nov. 28, 2025 /PRNewswire/ — YEAHKA Limited (Stock Code: 9923.HK), a leading commerce… CISION PRNewswireDecember 1, 2025
Business Press Release Singapore businesses lead in AI and data adoption, but face cybersecurity challenges Strong adoption of AI tools among Singapore businesses Current cybersecurity readiness can… CISION PRNewswireDecember 1, 2025
Press Release The Science of Longevity: Inside Prof. Mike Chan's Vision for Living Stronger, Smarter, and Longer BANGKOK, Dec. 1, 2025 /PRNewswire/ — Malaysia had a rare moment of… CISION PRNewswireNovember 30, 2025
Press Release The Bioregenerative Sports Revolution: How Prof. Mike Chan Is Changing Athlete Recovery — From Sabah to the Super Bowl KOTA KINABALU, Malaysia, Dec. 1, 2025 /PRNewswire/ — Big changes often start… CISION PRNewswireNovember 30, 2025
Press Release Perlis Royalty Join Prof. Mike Chan in Strengthening Malaysia's Fight Against Autism KUALA LUMPUR, Malaysia, Nov. 30, 2025 /PRNewswire/ — Malaysia’s drive to modernize… CISION PRNewswireNovember 30, 2025
Ascletis Selects Its First Oral GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development – Utilizing Ascletis’ Peptide Oral Transport ENhancement Technology (POTENT), ASC37 oral tablets… CISION PRNewswireNovember 30, 2025
Xinhua Silk Road: Discover China with foreign friends BEIJING, Nov. 30, 2025 /PRNewswire/ — Do you want to visit China?… CISION PRNewswireNovember 30, 2025
